This study describes the Osseointegration Group of Australia’s
Accelerated Protocol two-stage strategy (OGAAP-1) for the osseointegrated
reconstruction of amputated limbs. We report clinical outcomes in 50 unilateral trans-femoral amputees
with a mean age of 49.4 years (24 to 73), with a minimum one-year
follow-up. Outcome measures included the Questionnaire for persons
with a Trans-Femoral Amputation, the health assessment questionnaire
Short-Form-36 Health Survey, the Amputation Mobility Predictor scores
presented as K-levels, 6 Minute Walk Test and timed up and go tests.
Adverse events included soft-tissue problems, infection, fractures
and failure of the implant.Aims
Patients and Methods
Although patients with a history of venous thromboembolism
(VTE) who undergo lower limb joint replacement are thought to be
at high risk of further VTE, the actual rate of recurrence has not
been reported. The purpose of this study was to identify the recurrence rate
of VTE in patients who had undergone lower limb joint replacement,
and to compare it with that of patients who had undergone a joint
replacement without a history of VTE. From a pool of 6646 arthroplasty procedures (3344 TKR, 2907 THR,
243 revision THR, 152 revision TKR) in 5967 patients (68% female,
mean age 67.7; 21 to 96) carried out between 2009 and 2011, we retrospectively
identified 118 consecutive treatment episodes in 106 patients (65%
female, mean age 70; 51 to 88,) who had suffered a previous VTE.
Despite mechanical prophylaxis and anticoagulation with warfarin,
we had four recurrences by three months (3.4% of 118) and six by
one year (5.1% of 118). In comparison, in all our other joint replacements
the rate of VTE was 0.54% (35/6528). The relative risk of a VTE by 90 days in patients who had undergone
a joint replacement with a history of VTE compared with those with
a joint replacement and no history of VTE was 6.3 (95% confidence
interval, 2.3 to 17.5). There were five complications in the previous
VTE group related to bleeding or over-anticoagulation. Cite this article:
The use of autograft bone is the best option
when undertaking a procedure that requires bone graft because it
is osteogenic, osteoconductive and osseo-inductive. Pain, morbidity
and complications associated with harvesting iliac or non-iliac
sites occur in between 6% and 30% of cases. An alternative source
of graft with possibly a lower morbidity is the intramedullary canal.
In this study, 28 patients undergoing 30 arthrodesis procedures
on the hindfoot had a mean of 48 cm3 (43 to 50) of bone
harvested locally from the hindfoot or the tibial shaft by antegrade or
retrograde reaming. No patient sustained a fracture of the calcaneum,
talus or tibia. There was no morbidity except for one complication
when the reamer breached the medial tibial cortex. This healed uneventfully. This method of using the reamer–irrigator–aspirator system is
an extension of the standard technique of intramedullary reaming
of the lower limb: it produces good-quality bone graft with viable
growth factors consistent with that of the iliac crest, and donor
site morbidity is low. This is an efficient method of obtaining
autologous bone for use in arthrodesis of the ankle or hindfoot.
Diabetes mellitus is considered an indicator of poor prognosis for acute ankle fractures, but this risk may be specific to an identifiable subpopulation. We retrospectively reviewed 42 patients with both diabetes mellitus and an acute, closed, rotational ankle fracture. Patients were individually matched to controls by age, gender, fracture type, and surgical